Islet Transplant: an Option for Childhood Diabetes?
Overview
Affiliations
Careful assessment of the safety and efficacy of islet transplantation should guide the selection process of a small number of children with type 1 diabetes who may be eligible for the procedure--some of whom are already receiving immunosuppression because of a previous transplant, others who are scheduled to receive de novo islet alone transplantation because of a life threatening risk of hypoglycemia. The outcomes of these initial investigations are predicted to shape the future boundaries of islet transplantation, diabetes, and transplantation.
Human pluripotent stem cell-derived insulin-producing cells: A regenerative medicine perspective.
Migliorini A, Nostro M, Sneddon J Cell Metab. 2021; 33(4):721-731.
PMID: 33826915 PMC: 8117263. DOI: 10.1016/j.cmet.2021.03.021.
Regenerative medicine and cell-based approaches to restore pancreatic function.
Ellis C, Ramzy A, Kieffer T Nat Rev Gastroenterol Hepatol. 2017; 14(10):612-628.
PMID: 28811674 DOI: 10.1038/nrgastro.2017.93.
Edge J, Acerini C, Campbell F, Hamilton-Shield J, Moudiotis C, Rahman S Arch Dis Child. 2017; 102(6):543-549.
PMID: 28137708 PMC: 5466923. DOI: 10.1136/archdischild-2016-311530.
Song S, Roy S Biotechnol Bioeng. 2015; 113(7):1381-402.
PMID: 26615050 PMC: 5873326. DOI: 10.1002/bit.25895.
Krishnan R, Arora R, Alexander M, White S, Lamb M, Foster 3rd C Biomaterials. 2013; 35(3):891-8.
PMID: 24176195 PMC: 4057612. DOI: 10.1016/j.biomaterials.2013.10.012.